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Background: Sleep disturbance is commonly observed in patients with asthma, especially in 
those with poorly controlled asthma. Evaluating sleep quality to achieve good control of asthma 
is important since nocturnal asthmatic symptoms such as cough, wheezing, and chest tightness 
may disturb sleep. Actigraphy is an objective, ambulatory monitoring method for tracking a 
patient’s sleep and wake activities and for assessing sleep quality, as reflected by total sleep time, 
sleep efficiency, duration of awakening after sleep onset (WASO), and sleep onset latency.
Patients and methods: Fifty patients with asthma were enrolled in this study. Sleep quality 
was assessed employing wristwatch-type actigraphy (Actiwatch 2). The level of asthma control 
was assessed by the Asthma Control Questionnaire (ACQ), and asthma-related quality of life 
was assessed by the Asthma Quality of Life Questionnaire (AQLQ). The parameters for sleep 
quality were compared using ACQ scores, AQLQ scores, and pulmonary function test results.
Results: The total sleep time was 387.2 minutes, WASO was 55.8 minutes, sleep efficiency was 
87.01%, sleep onset latency was 8.17 minutes, and the average ACQ was 0.36. Neither sleep 
efficiency nor WASO correlated with respiratory functions, ACQ scores, or AQLQ scores.
Conclusion: Sleep-related parameters assessed by actigraphy in well-controlled asthma do not 
correlate with pulmonary functions, the asthma control level, or daytime quality of life. Sleep 
quality should be evaluated independently when asthma is well-controlled.
Keywords: asthma control, respiratory function, sleep efficiency, actigraphy
Introduction
Sleep disorders are classified into seven major categories and 60 disorders are listed 
in the International Classification of Sleep Disorders.1 Seven major categories 
are: 1)   insomnia; 2) sleep-related breathing disorders; 3) central disorders of 
  hypersomnolence; 4) circadian rhythm sleep–wake disorders; 5) parasomnias; 
6)   sleep-related movement disorders; and 7) other sleep disorders. Sleep-related asthma 
is one of the disorders categorized into other sleep disorders, and the essential features 
of sleep-related asthma are the same as those of nocturnal asthma, such as awakening 
with dyspnea, wheezing, coughing, air hunger, or chest tightness during sleep.1
The prevalence of sleep disturbance is reportedly 12.5%–19.7% in adult asthmatic 
patients2 and 38.95% in asthmatic children.3 Sleep disorders are known to be related to 
the severity of asthma and it has been reported that episodes of sleep-related asthma 
decrease in frequency and severity with effective treatment.4,5 However, recent studies 
have shown that sleep disorders are common in clinically stable asthmatic children.3,6 
Hanson and Chen reported that asthma symptoms did not predict self-reported sleep 
quality.7 Furthermore, Catterall et al described sleep itself as an important factor in International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
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determining overnight bronchoconstriction.8 Therefore, 
evaluating sleep disorders in asthma patients is important for 
improving both asthmatic symptoms and quality of life.
In clinical practice, questionnaires such as the Asthma 
Quality of Life Questionnaire (AQLQ) and the Asthma 
Control Questionnaire (ACQ) are commonly used to assess 
quality of life and asthma control in patients with asthma.9 
The health-related quality of life assessed by pediatric qual-
ity of life inventory is independent of asthma severity,10 and 
AQLQ scores did not correlate significantly with predicted 
forced expiratory volume in 1 second (FEV1), forced vital 
capacity (FVC), or predicted FVC.11 Luyster et al reported 
that sleep quality is associated with poor asthma control and 
quality of life.12
Recently, sleep evaluations by actigraphy in patients 
with a wide range of diseases, such as Alzheimer disease,13 
Parkinson’s disease,14,15 cancer,16 or rheumatoid arthritis,17 
have been reported. Actigraphy is also used for evaluating 
sleep disturbance in allergic rhinitis.18,19 Krouse et al reported 
the usefulness of actigraphy for evaluating the relationship 
between degrees of asthma control, as assessed by ACQ and 
AQLQ, and sleep quality.20 They reported that uncontrolled 
asthma patients took longer to fall asleep, awoke more often, 
and spent more time awake during the night than those with 
controlled asthma. However, respiratory functions were not 
evaluated in their study.
In the present study, we examined pulmonary functions, 
quality of life, and quality of sleep employing actigraphy in 
patients with adult asthma to assess relationships between 
asthma control, as evaluated by pulmonary function tests and 
the questionnaire, and sleep quality.
Patients and methods
Patients
Patients diagnosed as having asthma by respiratory physi-
cians according to the American Thoracic Society criteria21 
participated in this study. Written informed consent was 
obtained from all patients. Those who had been diagnosed 
with obstructive sleep apnea syndrome were excluded from 
this study.
Questionnaires
To assess the level of disease control in the patients with 
asthma, they were asked to answer the ACQ. We also 
assessed the quality of life of these patients employing the 
AQLQ. Daytime sleepiness was assessed by the Epworth 
Sleepiness Scale (ESS). These three questionnaire series 
were applied to complete the assessments between the first 
and the second visit in this study.
Assessing sleep quality by actigraphy
The actigraph is a light-weight wrist accelerometer 
  (Actiwatch 2; Philips Respironics, Murrysville, PA, 
USA). Actiwatch 2 has a light sensor and records a 
  digitally-integrated measure of gross motor activity, which 
can be used to visualize rest and activity patterns, quality of 
physical activity, and sleep. The patients were asked to wear 
an actigraph for 7 consecutive days and their sleep qualities 
were assessed by Actiware 5 software. Activity counts (AC) 
were collected from Actiwatch 2. We defined 60 seconds as 
1 epoch. Total activity counts were calculated by the follow-
ing formula:
A = 0.04E - 2 + 0.020E - 1 + E + 0.2E + 1 + 0.04E + 2 (1)
where A = total AC; E = AC during scored epoch; and 
En = AC during previous or successive epochs. Sleep was 
defined as the period when total AC were less than or equal 
to 40, which is regarded as the normal activity threshold for 
sleep analysis.22 We can assess total sleep time (minutes), 
sleep efficiency (%), duration of awakenings after sleep 
onset (WASO) (minutes), and sleep onset latency (minutes) 
according to the Actiware 5 software.
Measurement of respiratory functions 
and peak flow monitoring
From January 2011 to August 2011, all patients were 
asked to perform pulmonary function tests with a Chestac 
33   spirometer (Chest Co, Tokyo, Japan). The highest FVC 
and FEV1 values from a minimum of three pulmonary func-
tion tests were recorded. FEV1% is the FEV1 expressed as 
a percentage of the FVC (FEV1/FVC ×100). %FEV1 is the 
FEV1 expressed as a percentage of predicted values for sex 
and height using reference equations from Berglund et al.23 
All patients were also asked to measure the peak expira-
tory flow rate (PEFR) using a Mini-WRIGHT Peak-flow 
Meter (Clement Clarke, Harlow, UK). The patients recorded 
their PEFR twice a day, in the morning and in the evening, 
for 1 week and they wore an Actiwatch 2 to assess sleep qual-
ity during the same week while monitoring their PEFR.
Statistical analysis
GraphPad Prism 5 (GraphPad Software Inc., San Diego, 
CA, USA) was used for all statistical analyses. Values are International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
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presented as means ± standard error of the mean. Spearman’s 
correlation coefficients were used to examine correlations.
Results
characteristics of the patients
In total, 50 patients were enrolled in this study. However, the 
results obtained from eleven subjects could not be analyzed 
due to missing actigraphic or PEFR data, such that the data 
from 39 patients were used. The average age, sex, height, 
weight, average %PEFR, and pulmonary function test values 
(%FVC, FEV1, %FEV1) are shown in Table 1.
Actigraphy
Total sleep time (minutes), WASO (minutes), sleep 
  efficiency (%), and sleep onset latency (minutes) were 
  analyzed. The sleep time average was 387.2 minutes; WASO 
was 55.8   minutes; sleep efficiency was 83.0%; and sleep 
onset latency was 8.1 minutes (Table 2).
Relationships between sleep efficiency 
and pulmonary function tests
We evaluated the relationships between sleep efficiency and 
pulmonary function tests. Trends were seen between sleep 
efficiency and %FVC (Figure 1A), %FEV1 (Figure 1B), 
FEV1% (Figure 1C), and %PEFR (Figure 1D). Although 
there were slight tendencies for good FEV1% or %PEFR to 
be associated with good sleep efficiency, the relationships 
did not reach statistical significance.
relationships between WasO  
and pulmonary function tests
Next, we evaluated the relationships between WASO and 
pulmonary function tests. WASO showed no relationships 
with %FVC (Figure 2A), %FEV1 (Figure 2B), FEV1% 
(Figure 2C), or %PEFR (Figure 2D).
Relationships of sleep efficiency with 
WasO and minimum morning PeFr/
recent best PeFr
We calculated two PEFR indices from the consecutive 1-week 
PEFR monitoring results. One was the minimum morning 
value/maximum value which correlates with airway hyper-
responsiveness.24 The other was the morning dip (maximum 
value minus minimum value)/evening value, which is asso-
ciated with nocturnal asthma symptoms.25 We compared 
these indices with sleep efficiency and WASO but found no 
relationships (Figure 3).
epworth sleepiness scale and its 
relationship with sleep efficiency  
or WasO
The average ESS was 4.95 and three patients scored above 
11, which is thought to raise the possibility of sleep apnea 
syndrome being present. The relationships of ESS with 
sleep efficiency (Figure 4A) and WASO (Figure 4B) were 
not significant.
Correlations among ACQ score,  
sleep efficiency, WASO,  
and respiratory functions
We assessed the relationships among the ACQ score, sleep 
efficiency, WASO, and respiratory functions. The ACQ score 
did not correlate with sleep efficiency or WASO. However, 
the ACQ score showed negative correlations with average 
PEFR, %FVC, %FEV1, and FEV1% (Table 3).
Discussion
We assessed sleep quality, pulmonary functions, and quality 
of life in patients with asthma. We found that sleep quality 
is not related to respiratory functions or quality of life in 
asthma patients. We also found the level of asthma control, 
as assessed by ACQ, to not be associated with sleep   quality, 
though patients with severe airflow limitation tended to show 
lower sleep efficiency and longer WASO than those with 
mild and moderate airflow limitations.
Table 1 Patient characteristics
number of patients 39
Age (years) 57.4±16.1
Female/male 25/14
Height (cm) 158.8±6.7
Weight (kg) 57.4±9.5
BMI (kg/m2) 22.7±3.1
Average PEFR (%) 86.7±19.4
%FVc (FVc/FVc pred) 107.0±17.1
FeV1% (FeV1/FVC) 73.3±10.9
%FeV1 (FeV1/FeV1 pred) 98.8±20.4
Abbreviations:  FVC,  forced  vital  capacity;  FEV1,  forced  expiratory  volume  in 
1 second; PEFR, peak expiratory flow rate; pred, predicted.
Table 2 Actigraphy data
number of patients 39
Sleep time (min) 387.2±98.2
WASO (min) 55.81±22.68
Sleep efficiency (%) 87.01±5.42
Sleep onset latency (min) 8.17±7.26
Abbreviation: WASO, duration of awakenings after sleep onset.International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
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Figure 1 Correlations between sleep efficiency and pulmonary function tests.
Notes: Sleep efficiency shows no correlation with (A) %FVC, (B) %FEV1, (C) FEV1%, or (D) %PEFR.
Abbreviations: FeV1, forced expiratory volume in 1 second; PEFR, peak expiratory flow rate; pred, predicted; FVC, forced vital capacity.
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Krouse et al, using wrist actigraphy in ten patients with 
asthma, reported that the degree of asthma control cor-
related strongly with sleep quality. They showed that ACQ 
scores correlated positively with sleep onset latency, which 
means that poorly controlled asthma patients take a long 
time to fall asleep.20 They also showed correlations between 
ACQ scores or AQLQ scores and sleep efficiency, number 
of sleep episodes, and total time awake. In our study, neither 
ACQ scores nor AQLQ scores correlated significantly with 
any of the several parameters related to sleep quality. These International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
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Figure 3 Correlations between sleep efficiency or WASO and minimum morning value/maximum value or morning dip in PEFR.
Notes: Sleep efficiency shows no correlation with minimum morning value/maximum value (A) and morning dip (B). WASO also shows no correlations with minimum 
morning value/maximum value (C) and morning dip (D).
Abbreviations: PEFR, peak expiratory flow rate; WASO, duration of awakenings after sleep onset.
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Figure 4 Correlation between ESS and sleep efficiency or WASO.
Note: ESS correlates with neither sleep efficiency (A) nor WASO (B).
Abbreviations: ESS, Epworth Sleepiness Scale; WASO, duration of awakenings after sleep onset.
parameters also showed a negative correlation between ACQ 
and AQLQ. We also found that ACQ and AQLQ showed a 
significant correlation, though that of ACQ was very low 
(data not shown). In our study, the level of asthma control 
was very good according to the average ACQ scores (0.36). 
On the other hand, the level of asthma control was worse 
(ACQ 2.20 at first visit and 1.93 at second visit) in Krouse 
et al’s study.20 This discrepancy is thus attributable to the 
difference in asthma control levels between the two study 
groups.
Many patients with asthma reportedly have daytime 
sleepiness.26,27 Mastronarde et al27 studied sleep disturbance 
in symptomatic asthma patients using the ESS. They 
showed that ESS scores averaged 8.5±4.9 in 487 subjects. 
Krouse et al also reported that the average ESS score was 
9.20 and that four of their ten patients (40%) had scores 
over 10.20 In our study, the average ESS score was low 
(4.95±3.81) and only three of the 39 patients (7.6%) had 
scores over 10. Furthermore, there was no significant cor-
relation between ESS scores and either sleep efficiency 
or WASO. These results suggested that our study subjects 
were well controlled in terms of nocturnal symptoms and 
that subjects with obstructive sleep apnea syndrome were 
apparently excluded, despite the prevalence of obstructive 
sleep apnea in asthma being high,28 especially in patients 
with severe asthma.29,30International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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emergency room visits, and poorer survival.39 These findings 
are different from previous studies for patients with asthma. 
  However, patients with asthma who are elderly and have smok-
ing history sometimes show features of COPD (asthma–COPD 
overlap syndrome).40 Since patients with asthma–COPD over-
lap syndrome might show more sleep disturbance compared to 
patients with asthma or COPD alone, further studies are needed 
to assess the relationship among sleep quality, pulmonary func-
tions, exacerbations, and mortality in these patients.40
The total sleep time in patients with asthma in this study 
averaged 387.2 minutes. The average sleep time of nonasth-
matic patients was 389.9 minutes,41 as assessed by actigraphy. 
The average sleep time of Japanese subjects studied is 413 
minutes, as assessed by questionnaire,42 while patients with 
nocturnal asthma had shorter sleep times than normal sub-
jects.43 Although different methods for evaluating sleep might 
influence actual total sleep time, the total sleep time of our 
study subjects is likely to be similar to that of nonasthmatic 
patients. Kripke et al investigated the relationship between 
mortality and actigraphic sleep time.44 They adjusted for 
survival functions and estimated that 61% of subjects slept 
less than 300 minutes and that survival was 78% for subjects 
sleeping longer than 390 minutes. The subjects with sleep 
durations ranging from 300 to 390   minutes had a survival 
rate of 90%. The actigraphic sleep time of the patients in this 
study appears to be favorable, but further studies are needed to 
determine whether sleep time influences mortality in subjects 
with well-controlled asthma.
A limitation of this study is that we failed to evaluate 
comorbidities in our asthma patients. In adult patients with 
asthma, nasal congestion due to rhinitis, obesity, and smok-
ing all impact the risk of insomnia.45 Furthermore, asthma-
associated comorbidities, such as sleep apnea syndrome 
and gastroesophageal reflux, influence both asthma severity 
and sleep disorders.5,12,46,47 We were also unable to assess 
drug side-effects, including those of oral corticosteroids, 
methylxanthine, antidepressants, and hypnotic drugs, which 
can affect sleep quality. We thought that the duration of the 
study period might be too short to evaluate sleep quality in 
well-controlled asthma. Further study is necessary to clarify 
these points.
Conclusion
In conclusion, sleep quality in well-controlled asthma is not 
related to parameters of pulmonary function or to assess-
ments of asthma-associated quality of life. Sleep disturbance 
might be related not only to asthma control but also to other 
conditions such as comorbidities or drugs.32 Among patients 
Table 3 Correlation of ACQ and AQLQ with sleep efficiency, 
WASO, and respiratory functions
ACQ AQLQ
Sleep efficiency (%) 0.1169 -0.0359
WASO (min) 0.1817 0.1280
Mean %PeFr -0.3657* 0.4744**
%FVc (FVc/FVc pred) -0.4933** 0.5293**
%FeV1 (FeV1/FeV1 pred) -0.5560** 0.4449**
FeV1% (FeV1/FVC) -0.3454* 0.1591
Notes: *P,0.05. **P,0.01.
Abbreviations:  ACQ, Asthma Control Questionnaire; AQLQ, Asthma Quality of Life 
Questionnaire; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; 
PEFR, peak expiratory flow rate; pred, predicted; WASO, duration of awakenings 
after sleep onset.
Luyster et al reported that poor sleep quality is an inde-
pendent predictor of worse asthma control and quality of 
life in both nonsevere and severe asthma patients.12 In their 
study, sleep quality was assessed employing Pittsburgh 
Sleep Quality Index scores, which are derived from a self-
reported questionnaire designed to measure sleep quality for 
the past 1 month.31 They reported that poor sleep quality is 
associated with poor asthma control but not nighttime asthma 
  disturbance. Braido et al also suggested that in real life, poor 
sleep might be independent of nighttime asthma symptoms 
even when asthma is well controlled.32 Therefore, our data 
related to sleep may represent the actual sleep situation of 
patients with asthma which is well controlled.
In this study, we assessed the correlations among pulmonary-
function parameters (%FVC, %FEV1, FEV1%, and PEFR), sleep 
quality parameters (sleep efficiency and WASO), and AQLQ. 
We found no relationships between the parameters of sleep and 
asthma-related quality of life. Furthermore, pulmonary functions 
correlated with neither sleep efficiency nor WASO. However, 
asthma-related quality of life and pulmonary-function param-
eters showed significant positive correlations. These results 
suggest pulmonary functions to possibly be related to daytime 
quality of life, but not sleep quality in patients with asthma. 
Since health-related quality of life reportedly shows only a weak 
correlation with pulmonary-function parameters in patients with 
asthma,33,34 sleep quality should be assessed individually based 
on pulmonary function tests and the AQLQ.
Chronic obstructive pulmonary disease (COPD) is a 
common preventable and treatable disease, characterized by 
persistent airflow limitation.35 Sleep disturbance in COPD is 
common36,37 and associated with oxygen desaturation, cardiac 
arrhythmia, pulmonary hypertension, and nocturnal death.38 
Omachi et al reported that sleep disturbance was associ-
ated with cough, dyspnea, and COPD severity. They have 
shown that sleep disturbance predicted COPD exacerbations, International Journal of General Medicine 2014:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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with asthma, sleep quality should be assessed independently 
when asthma is well controlled.
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